Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
18 avr. 2024 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Tiziana Life Sciences Announces Platform Presentation of New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
11 avr. 2024 07h00 HE
|
Tiziana Life Sciences Ltd.
Tiziana Life Sciences Announces Platform Presentation of New Quantitative PET Imaging Data on Foralumab at the American Academy of Neurology
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at Eyecelerator 2024, a Partner Meeting of the American Society for Cataract and Refractive Surgery
02 avr. 2024 07h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
Fortuna to present at the Gold Forum Europe 2024 in Zürich, Switzerland
25 mars 2024 05h00 HE
|
Fortuna Silver Mines Inc.
VANCOUVER, British Columbia, March 25, 2024 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) is pleased to announce that it will be attending Gold Forum Europe 2024, which is...
Arbutus to Participate in Two Upcoming Investor Conferences
08 mars 2024 07h30 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., March 08, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
Tiziana Life Sciences Announces Podium Presentation at AD/PD of Nasal Anti-CD3 in Alzheimer’s Disease
05 mars 2024 07h00 HE
|
Tiziana Life Sciences Ltd.
Data shows reduction of microglia activation and improvement in behavior in rodent models of Alzheimer’s disease (AD) and Parkinson’s disease (PD)Nasal anti-CD3 reduced hemorrhage and edema that...
ATN to Present at Sidoti Spring 2024 Small Cap Virtual Investor Conference on March 14, 2024
27 févr. 2024 16h35 HE
|
ATN International, Inc.
BEVERLY, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- ATN International, Inc. (Nasdaq: ATNI), a leading provider of digital infrastructure and communications services, today announced that Chief...
mdf commerce annonce la date de la conférence téléphonique sur les résultats financiers du troisième trimestre de l'exercice 2024
30 janv. 2024 08h00 HE
|
mdf commerce inc.
MONTRÉAL, 30 janv. 2024 (GLOBE NEWSWIRE) -- mdf commerce inc. (TSX:MDF), un leader des technologies de commerce électronique de type logiciel-service (« SaaS »), tiendra une conférence...
mdf commerce announces the date of the conference call for third quarter of fiscal year 2024 financial results
30 janv. 2024 08h00 HE
|
mdf commerce inc.
MONTREAL, Jan. 30, 2024 (GLOBE NEWSWIRE) -- mdf commerce inc. (TSX: MDF), a SaaS leader in digital commerce technologies, will hold a conference call to discuss third quarter of fiscal year 2024...
Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024
05 janv. 2024 09h30 HE
|
Tiziana Life Sciences Ltd.
Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024